Brief: Prime Medicine, Inc. Q3 EPS USD -0.32
07/11/2025 12:00
Nov 07 (Reuters) - Prime Medicine, Inc. Q3 income from operations USD -53.973 million. Q3 operating expenses USD 55.198 million Q3 net income USD -50.582 million
Recent news on Prime Medicine
See all newsBrief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm647 In Alpha-1 Antitrypsin Deficiency
Prime Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Prime Medicine Q2 net loss narrows on lower expenses
Brief: Prime Medicine, Inc. Q2 EPS USD -0.24
Brief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm577a In H1069q-Mutated Wilson Disease